Cancer Molecular Genetics/Early Detection Program

Program goal and objectives
This program aims to understand the basic molecular mechanism of tumorigenesis, identify biomarkers for early detection and targets for therapeutic intervention.

Members
Kounosuke Watabe, Ph.D. (tumor biology, metatases)
Yin-Yuan Mo, Ph.D. ( tumor cell biology, drug resistance)
Jodi Huggenvik, Ph.D. (tumor biology, tumor suppressors)
Mike Collard, Ph.D. (tumor biology, tumor suppressors)
Blaine Bartholomew, Ph.D. (cell biology, chromatin structure)
Rita Trammell, Ph.D (tumor immunology, sarcoma)
Lydia A. Arbogast, Ph.D. ( hormone and cancer )
Jena Steinle, Ph.D. ( tumor angiogenesis )
Sukesh R. Bhaumik, Ph.D. (Gene expression, DNA repair and cancer)
Subhas Chakrabarty, Ph.D. (epigenomic remodeling and differentiation control)
Randolph Elble, Ph.D. (cancer biology, tumor suppressors, CLCA protein)
Deliang Cao, Ph.D. (metabolic pathways, antitumor activity & tumor selectivity)
Daotai Nie, Ph.D. (molecular ordering in tumor progression)

---

Experimental Therapeutics/Prevention Program

Program goal and objectives
This program focuses on the development of new methodologies for cancer therapy and prevention.

Members
Elizabeth Peralta, M.D. (breast cancer, chemoprevention)
Sophia Ran, Ph.D. (tumor biology, angiogenesis)
Krishna Rao, M.D. (tumor genetics, breast cancer)
Tom Tarter, M.D. (renal cancer)
Amy Arai, Ph.D. (neuroblastoma)
Vickram Ramkumar, Ph.D. (signal transduction, chemotherapy)
Leonard Rybak, M.D. (chemotherapy, drug sensitivity)
Mary McAsey, Ph.D. (gynecologic cancer, chemoprevention)
Kathy Campbell, Ph.D. (chemotherapy, anti-cancer drug)
Gregory Brewer, Ph.D. (brain cancer)
Laura Murphy, Ph.D. (breast cancer, chemoprevention)
Yuqing Hou, Ph.D. (chemoprevention)
Laura Rogers, M.D. (exercise and cancer)
James Malone, M.D. (head and neck cancer, lymphangiogenesis)
Subhas Chakrabarty, Ph.D. (chemoprevention of colon cancer)